We have detected that you are using an Ad Blocker. PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Explore
Metastatic Breast Cancer
Center of Excellence
Interested in receiving weekly updates about the Metastatic Breast Cancer Center of Excellence?
You can find your saved items on your dashboard, in the "saved" tab.
You've recommended your first item
Your recommendations help us improve our content suggestions for you and other PracticeUpdate members.
You've subscribed to your first topic alert
What does that mean?
Each day, we'll check to see if new items have been published to the topics you're subscribed to, and we'll send you one email with all of the new items from that day.
We'll keep all topic alert notifications available on your dashboard for 30 days, to make sure you don't miss anything.
Lastly, whenever you have unread items in the topics you've subscribed to, the "Alerts" icon will light up in the main menu. Just click on the bell to see your five most-recent, unread notifications.
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
No comments yet, be the first to start the discussion!
Comment deleted by Moderator.
Comment deleted by Moderator.
Comment deleted by Moderator.
Beata Kania-Zembaczyńska
Nov 25, 2016
New hormone positive breast cancer
Mastectomy with slnd,and hormonotherapy -tamoxifen
Guy Lesec
Nov 26, 2016
The phenotype is close to the previous one, but we do not know if the grade is different and whether it is a luminal A or B. (KI 67?). However, recurrences are often more evolutive (3 cm): therefore, it is necessary to propose a total matectomy with axillary dissection, with the aid of a colored and radioactive tracer, but completing by a wider dissection given the cicatrational state of the lymphatic path. The other decisions depend on the new staging. A new-generation hormone therapy is in any case indicated
nagib khoury
Nov 26, 2016
most probably a new breast cancer,developped in a different quandrant..if us of the axilla is negative consider total mastectomy because of the size of the tumor.Breast irradiation can be added . post op palbociclib and fulvestrant is one option
Nguyen Minh Tinh
Nov 27, 2016
I think this is recurrent Breast Cancer
I recomment surgical for breast not axilla LND
May be adjuvant RT
Systemic thẻapy: chemo follow Hormon
Oda Abushaban
Dec 25, 2016
This is recurrence B C need for MRM with axilla ,adjuvant RT and Tomoxfen +follow up
pramod kumar julka
Feb 08, 2017
it is new breast cancer Mastectomy with sentinal lymph node dissection .genetic assay oncotype dx or endopredict may be done if low risk PALBOCICLIB &FULVUSTRANT MAY BE GIVEN OTHERWISE CHEMOTHERAPY
Juan Rodriguez Agostini
Feb 09, 2017
I think it is a reccurrence from initial tumor. The therapeutic option is total mastectomy + SLNB (re-mapping) + Axillary clearance if SLN is positive. Radiation may be omitted if we do a total mastectomy. Systemic treatment: hormonal therapy with another AI (exemestane for example)
mouna kairouani
Feb 19, 2017
I think it is a recurrent breast cancer. I propose mastectomy with axillary dissection. The patient has already received radiotherapy. This is a secondary endocrine resistance with a relapse on the third year of hormone therapy. It is important to precise the ki 67 and score of oncotype dx for decision
Muhammad Jawaid Akhter Malick
May 26, 2018
In my opinion this is recurrent disease. Mastectomy +Ald. Then my look for recurrence score. Manage according to the recurrence rate, second line hormone therapy + xrt to axila + sup.clav. If high risk then chemotherapy followed by above.
pramod kumar julka
May 28, 2018
This is a new lesion. This may be treated by breast conservation surgery and put on hormones.
pramod kumar julka
May 28, 2018
This is a new lesion. This may be treated by breast conservation surgery and put on hormones.
Apr 19, 2024
Pending Moderator approval.
Are you sure you want to delete this comment? This can't be undone.
Sameer
Nasir
MD
Beata Kania-Zembaczyńska
Nov 25, 2016
Guy Lesec
Nov 26, 2016
nagib khoury
Nov 26, 2016
Nguyen Minh Tinh
Nov 27, 2016
Oda Abushaban
Dec 25, 2016
pramod kumar julka
Feb 08, 2017
Juan Rodriguez Agostini
Feb 09, 2017
mouna kairouani
Feb 19, 2017
Muhammad Jawaid Akhter Malick
May 26, 2018
pramod kumar julka
May 28, 2018
pramod kumar julka
May 28, 2018
Apr 19, 2024
Pending Moderator approval.